Evidence map›Paper›PMID 29127144›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Disruption of Thrombocyte and T Lymphocyte Development by a Mutation in

Raz Somech, Atar Lev, Yu Nee Lee, Amos J Simon, Ortal Barel, Ginette Schiby, Camila Avivi, Iris Barshack, Michele Rhodes, Jiejing Yin and 10 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Raz SomechPediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 52621, Israel.
Atar LevPediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 52621, Israel.
Yu Nee LeePediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 52621, Israel.ORCID 0000-0001-8648-5253
Amos J SimonPediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 52621, Israel.
Ortal BarelThe Wohl Institute for Translational Medicine, Sheba Medical Center, Tel Hashomer, Tel Aviv 52621, Israel.
Ginette SchibyDepartment of Pathology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 52621, Israel.
Camila AviviDepartment of Pathology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 52621, Israel.
Iris BarshackDepartment of Pathology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 52621, Israel.
Michele RhodesBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111.
Jiejing YinBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111.
Minshi WangBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111.ORCID 0000-0002-0225-0586
Yibin YangBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111.
Jennifer RhodesBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111.ORCID 0000-0001-7298-1213
Nufar MarcusAllergy and Immunology Unit, Schneider Children's Medical Center of Israel, Felsenstein Medical Research Center, Kipper Institute of Immunology, Petach Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 4920235, Israel.
Ben-Zion GartyAllergy and Immunology Unit, Schneider Children's Medical Center of Israel, Felsenstein Medical Research Center, Kipper Institute of Immunology, Petach Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 4920235, Israel.
Jerry SteinBone Marrow Transplantation Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 4920235, Israel; and.ORCID 0000-0001-6352-6956
Ninette AmariglioThe Wohl Institute for Translational Medicine, Sheba Medical Center, Tel Hashomer, Tel Aviv 52621, Israel.
Gideon RechaviThe Wohl Institute for Translational Medicine, Sheba Medical Center, Tel Hashomer, Tel Aviv 52621, Israel.
David L WiestBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111; yong.zhang@fccc.edu david.wiest@fccc.edu.ORCID 0000-0002-0792-3188
Yong ZhangBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111; yong.zhang@fccc.edu david.wiest@fccc.edu.
Tel Aviv University · ILFox Chase Cancer Center · USBar-Ilan University · IL

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
University of Texas M.D. Anderson Cancer SPORE-LeukemiaP50CA100632 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KONOPLEVA, MARINA Y · 2003 to 2023
$43.7M
TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell LymphomaK22CA197014 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI YANG, YIBIN · 2016 to 2018
$584k
Functional Analysis of Candidate Genes in Primary T Cell ImmunodeficienciesR21AI111208 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI PUCK, JENNIFER M., WIEST, DAVID L. · 2014 to 2015
$467k
NCI NIH HHS K22 CA197014NCI NIH HHS P30 CA006927NCI NIH HHS P50 CA100632NCI NIH HHS T32 CA009035NIAID NIH HHS R21 AI111208
6 · The paper itself

Abstract

Regulation of the actin cytoskeleton is crucial for normal development and function of the immune system, as evidenced by the severe immune abnormalities exhibited by patients bearing inactivating mutations in the Wiskott-Aldrich syndrome protein (WASP), a key regulator of actin dynamics. WASP exerts its effects on actin dynamics through a multisubunit complex termed Arp2/3. Despite the critical role played by Arp2/3 as an effector of WASP-mediated control over actin polymerization, mutations in protein components of the Arp2/3 complex had not previously been identified as a cause of immunodeficiency. Here, we describe two brothers with hematopoietic and immunologic symptoms reminiscent of Wiskott-Aldrich syndrome (WAS). However, these patients lacked mutations in any of the genes previously associated with WAS. Whole-exome sequencing revealed a homozygous 2 bp deletion, n.c.G623DEL-TC (p.V208VfsX20), in Arp2/3 complex component

Indexed as

Frameshift MutationActin CytoskeletonActin-Related Protein 2-3 ComplexBlood PlateletsChild, PreschoolCodon, NonsenseConsanguinityFatal OutcomeHumansImmunologic Deficiency SyndromesInfantLymphopoiesisMaleMultiprotein ComplexesPedigreePolymerizationActin-Related Protein 2-3 ComplexARPC1B protein, humanCodon, NonsenseMultiprotein ComplexesZebrafish Proteins

Identifiers

PMID29127144
PMCPMC5726601
OpenAlexW2767728771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.